Clinical Trials Logo

Filter by:
NCT ID: NCT03271957 Not yet recruiting - Clinical trials for Manual Rotation of A Liveborn

Manual Rotation in Persistent Occiput Posterior Position

Start date: October 1, 2017
Phase: N/A
Study type: Observational

Is part of routine obstetric care to attempt a manual rotation in all fetus that are in a persistent OP at delivery. Nevertheless, little is known about the success of this intervention or about the relation of some ultrasound measures with the outcome.

NCT ID: NCT03129477 Not yet recruiting - COPD Clinical Trials

TELE-monitoring in Chronic Obstructive Pulmonary Disease

TELECOPD
Start date: January 1, 2019
Phase: N/A
Study type: Interventional

COPD is the fourth cause of death worldwide and it is expected to be the third in 2020. Non-invasive ventilation (NIV) has a positive impact in reducing mortality related to chronic respiratory failure in stable patients with COPD. Moreover, the addition of home NIV to home oxygen therapy reduces hospital admissions and improves patients outcomes. Patients monitoring is crucial. It is increasingly recognized the potential of telemedicine in reducing morbidity and mortality, as well as healthcare utilisation and its associated costs. In particular, home telemonitoring (TM)- a technology measuring patients`clinical parameters and symptoms at home and allowing communication between healthcare professionals and patients over distance- has gained much attention. However, despite a growing body of evidence for TM in the management of COPD and other chronic diseases, the benefit of telemonitoring for Home mechanical ventilation concerning clinical and economic outcomes remains to be clearly demonstrated. The study aims to assess the impact that telemonitoring would have NIV efficacy, patient quality of life and satisfaction, through a prospective randomized study.The primary endpoint is the time for appropriate adaptation and therapy efficacy, defined as average SatO2 to 90% in 24h oximetry.

NCT ID: NCT03111615 Not yet recruiting - Clinical trials for Breast Cancer Female

HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer

HOTBreast
Start date: May 1, 2018
Phase: Phase 4
Study type: Interventional

Breast Cancer is a public health issue worldwide. The time from diagnosis to treatment initiation varies from country to country and regionally within a country. Early diagnosis and prompt treatment initiation are key factors in patient survival rates. Currently there is a rising trend, with a high percentage of patients with "Luminal" like breast cancer only undergoing adjuvant endocrine therapy. Authors argue that tumor biology alterations after introducing very early endocrine therapy might have a prognostic and therapeutic impact and should be studied.

NCT ID: NCT03017976 Not yet recruiting - Asthma Clinical Trials

Swimming Pool Environment Impact on the Human Respiratory Health

SWAN
Start date: January 2017
Phase: N/A
Study type: Observational

This study aims to assess the influence of exposure to swimming pool environment on respiratory symptoms and diseases, and on cancer outcomes among swimmers and swimming pool attendants.

NCT ID: NCT01971268 Not yet recruiting - Bone Loss Clinical Trials

Compare the Success Rate of T3 Dental Implant (Biomet 3I) With or Without Platform-switch Concept

Start date: January 2014
Phase: N/A
Study type: Observational

In patients that received a T3 (Biomet 3I) dental implant, does the use of platform-switch concept compared to the use of platform-matched concept, refrain marginal bone loss during osseointegration phase (t=12 weeks =T1) and from then to final rehabilitation (t= placement of the final restoration = at 18 weeks=T2)

NCT ID: NCT01970826 Not yet recruiting - Bone Loss Clinical Trials

Compare Sterilized Clean vs Sterilized Aseptic Dental Implant Surgery

Start date: January 2014
Phase: N/A
Study type: Interventional

In patients that require dental implants , does performing the surgery in clean sterile field compared to aseptic field, produces more post-operatory complications, implant morbidity or patient discomfort ?

NCT ID: NCT01963884 Not yet recruiting - Alveolar Bone Loss Clinical Trials

Relate Tooth Alveolar Extraction Socket Anatomy to Alveolar Remodeling Rate

Start date: January 2014
Phase: N/A
Study type: Observational

In patients that are going to be subjected to a tooth extraction in the anterior maxillary (from canine to canine) does the position of the intact alveolar socket related to maxillary basal bone interferes with the rate of resorption and remodeling process of the alveolar ridge ?

NCT ID: NCT01574924 Not yet recruiting - Coping Skills Clinical Trials

Personality Change During Medical Residency

Start date: April 2012
Phase: N/A
Study type: Observational

The Ethics Committee of Hospital and University Center of Coimbra (Portugal) complies, reports and is supervisioned by the Portuguese Ethics Committee. The Ethics Committee of Hospital and University Center of Coimbra is an multidisciplinary organ of Ethics experts that give support to the board of hospital directors, the health personnel and patients, regarding bioethical issues emerging from clinical assistance activities (addressed to patient's health being, education and clinical research).

NCT ID: NCT01492478 Not yet recruiting - Depression Clinical Trials

Psychobiological Characterization of Depression in Hepatitis C

Start date: January 2012
Phase: N/A
Study type: Observational

The aim of this study is to do an evaluation of the clinical profile of depression in HCV patients (newly diagnosed and treatment naïve), and in these same individuals, 24 weeks after the beginning of IFN+Ribavirin therapeutics (n=100). To characterize depression associated to HCV with and without interferon (IFN), the investigators will use clinical, behavioral, biochemical and genetic markers, and to distinguish their different symptomatologic dimensions. The control group will be composed by 100 individuals with Major Depression diagnosis, and not from the general population, because the investigators are not trying to study the incidence of depression in general population, but to characterize the clinical profile of patients with HCV (IFN+Ribavirin) compared to major depression. Thus, the investigators will total 300 evaluations in 200 individuals, 100 from each group, and considering that the clinical group will be evaluated before the therapeutics and re-evaluated 24 weeks after its beginning. Hypotheses 1. Depression in individuals affected by HCV is associated to genetic vulnerability. 2. Genetic vulnerability increases the risk of depression when IFN therapeutics is used. 3. Depression associated to infection by HCV presents a symptomatological profile that is different from general depression, which is maintained with IFN therapeutics. 4. A higher state of depression in the beginning of a treatment, if not treated, is a risk factor to abandoning therapeutics. 5. When comparing genders, women present a more severe symptomatological profile than men.

NCT ID: NCT01417455 Not yet recruiting - Clinical trials for Kinetics of Bone Cells Differentiation and Activity in Untreated RA and AS Patients.

Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing Spondylitis

Start date: January 2012
Phase: N/A
Study type: Observational

Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are characterized by chronic systemic inflammation and share common pathogenic pathways. In both diseases, cytokines like TNF and IL-17, known for their pro-inflammatory and osteoclastogenic effects, are relevant players, however, while RA is characterized by bone erosions, AS favors bone overgrowth. Understanding this paradox may hold the key for a better management of both diseases. Our hypothesis is that there are differences in the cellular environment and intracellular signaling between AS and RA. To test this hypothesis we will evaluate the cytokine milieu, the kinetics of bone cells differentiation and their activity in untreated and immunosuppressed RA and AS patients. We will also perform the same observations in patients exposed to targeted treatments.